Clinical Trials to Validate AI-Driven Drug Repurposing 2026
Offered by Partnership for Cures · Chicago, IL
About this opportunity
Accepts investigator-initiated, proof of concept, Phase I or Phase IIA clinical trials to validate artificial intelligence (AI)-driven repurposing opportunities in any unsolved disease, where therapies supported by AI models are already approved. Eligible trials must include AI-generated data as part of preclinical support. Budget up to $100,000 including 10% institutional match, with additional funds available for community engagement.
How to apply
Applications are handled on the funder's own website. Review the full guidelines and apply here: proposalcentral.com. Confirm the deadline and eligibility directly with Partnership for Cures before applying.
See Partnership for Cures's full giving profile — its grant history, top recipients, and other funding priorities.
Is this grant a fit for your nonprofit?
Before you spend hours on an application, know whether it's worth it. Bespoke Grants scores any open RFP against your mission, budget, and service area — and finds the other funders you're missing. Free, no credit card.
Check my fit & find more grants →Other open opportunities from Partnership for Cures
Partnership for Cures currently lists 3 open opportunities in our index.
- Clinical Repurposing Research to Impact Veterans/Military 2026
- ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries 2026
Frequently asked questions
- What is the deadline for Clinical Trials to Validate AI-Driven Drug Repurposing 2026?
- The application deadline is June 26, 2026. Deadlines can change — always confirm directly with Partnership for Cures before applying.
- How much funding is available?
- The award range is Up to $100K.
- Where do I apply?
- Applications are submitted through Partnership for Cures's own website or process — see the "How to apply" section above.